Injective

Blockchain technology for Decentralized Finance & Web3 Innovation

Headquarters
San Francisco
Employees
51–200
Founded
2018
Business Model
platform
Total Funding
$203.0M
Last Round
$40.0M Venture RoundMar 2026
Rounds
4

About

Injective is a high-performance Layer 1 blockchain purpose-built for decentralized finance and Web3 financial applications, founded by Eric Chen and Albert Chon in 2018 through Binance Labs' first incubation program. The protocol provides out-of-the-box modules for building sophisticated DeFi apps including derivatives, cross-chain margin trading, synthetic assets, and futures markets. Based in New York City, Injective Labs has raised over $57M from investors including Binance, Pantera Capital, Jump, and Brevan Howard.

Tech & App Stack

Tech & App Stack is available on paid plans

Upgrade to Silver or higher to reveal the full technology and app stack for any company.

View pricing

Sign up to view funding chart

Create a free account to see funding visualizations and detailed round data.

Create Free Account

Funding History

Venture UnknownFunding RoundMar 2026
Venture UnknownVenture RoundMar 2026
Series BSeries BAug 2021
Series ASeries AOct 2020

Investors

Sign up to view investors

Create a free account to see which investors have funded this company.

Create Free Account

Similar Companies